Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates-Reference-Cited by-同舟云学术

Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates

Published:2023-10 Issue:10 Volume:56 Page:2408-2424.e6
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

He Wenhui,Ou Tianling,Skamangas Nickolas,Bailey Charles C.,Bronkema Naomi,Guo Yan,Yin Yiming,Kobzarenko Valerie,Zhang Xia,Pan Andi,Liu Xin,Xu Jinge,Zhang Lizhou,Allwardt Ava E.,Mitra Debasis,Quinlan Brian,Sanders Rogier W.,Choe Hyeryun,Farzan Michael

Funder

NIAID

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference82 articles.

1. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target;Walker;Science,2009

2. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1;Wu;Science,2010

3. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus;Liao;Nature,2013

4. Broadly neutralizing antibodies against HIV-1: templates for a vaccine;van Gils;Virology,2013

5. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice;Halper-Stromberg;Cell,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affinity maturation of CRISPR-engineered B cell receptors in vivo;Nature Biomedical Engineering;2024-03-20

2. In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies;Nature Biomedical Engineering;2024-03-14

3. In vivoaffinity maturation of the HIV-1 Env-binding domain of CD4;2024-02-05